science_technology_and_other_research_and_development · DOD-AMRAA

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

Defense Health Agency Contracting Activity - DHACA · HT942526TBDRPTDRA

61 days left

Total Program Funding

$2.6M

Expected Awards

Deadline

October 22, 2026

GRANTQUICK SUMMARYPlain-English Overview

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award. Defense Health Agency Contracting Activity - DHACA. Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other... $2,650,000 total program funding; ~2 awards expected.

Who Should Apply

Unrestricted (any eligible entity)

Who Should NOT Apply

Few restrictions — most eligible entities can apply

Key Requirements (Plain English)

•Deadline: 2026-10-22

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings.

https://cdmrp.health.mil/pubs/press/2026/tbdrppreann